Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Enseval Putera Megatrading Tbk ROE % Adjusted to Book Value Chart
ISX:EPMT vs MCK, COR, CAH: ROE % Adjusted to Book Value Comparison
For the Medical Distribution subindustry, PT Enseval Putera Megatrading Tbk's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Enseval Putera Megatrading Tbk ROE % Adjusted to Book Value vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, PT Enseval Putera Megatrading Tbk's ROE % Adjusted to Book Value distribution charts can be found below:
* The bar in red indicates where PT Enseval Putera Megatrading Tbk's ROE % Adjusted to Book Value falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROE % Adjusted to Book Value of 17.24% mean?
PT Enseval Putera Megatrading Tbk (ISX:EPMT) has a ROE % Adjusted to Book Value of 17.24% as of Mar. 2026. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on PT Enseval Putera Megatrading Tbk and its competitors.
Is PT Enseval Putera Megatrading Tbk's ROE % Adjusted to Book Value too high?
PT Enseval Putera Megatrading Tbk's current ROE % Adjusted to Book Value is 17.24%. Overall, PT Enseval Putera Megatrading Tbk has a GF Score™ of 89/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PT Enseval Putera Megatrading Tbk's ROE % Adjusted to Book Value compare to MCK and COR?
PT Enseval Putera Megatrading Tbk's ROE % Adjusted to Book Value of 17.24% can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Medical Distribution company?
A good ROE % Adjusted to Book Value depends on the Medical Distribution industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on PT Enseval Putera Megatrading Tbk and its competitors. PT Enseval Putera Megatrading Tbk's current ROE % Adjusted to Book Value is 17.24%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Enseval Putera Megatrading Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Enseval Putera Megatrading Tbk (ISX:EPMT) is currently considered Modestly Undervalued. The stock's GF Value™ is Rp2,689.14, compared to a current price of Rp2,360.00 — trading 12.2% below its estimated fair value. The current ROE % Adjusted to Book Value is 17.24%. PT Enseval Putera Megatrading Tbk's overall GF Score™ is 89/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For PT Enseval Putera Megatrading Tbk (ISX:EPMT), the current ROE % Adjusted to Book Value is 17.24% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Enseval Putera Megatrading Tbk (ISX:EPMT) Overvalued in 2026?
Based on GuruFocus' analysis, PT Enseval Putera Megatrading Tbk stock appears to be undervalued.
The current stock price of Rp2,360.00 is trading 12.2% below its estimated GF Value™ of Rp2,689.14.
GuruFocus considers PT Enseval Putera Megatrading Tbk to be Modestly Undervalued.
Key valuation signals for ISX:EPMT:
ROE % Adjusted to Book Value: 17.24%
GF Value™: Rp2,689.14 vs. price of Rp2,360.00 (12.2% below fair value)
No single metric tells the full story. See the ISX:EPMT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Enseval Putera Megatrading Tbk is a general distributor dealing in pharmaceutical products, consumer products, and medical devices. The company also acts as an agent and distributor of consumer goods, prescription medicines, non-prescription medicines, raw materials for the pharmaceutical, medical equipment, including marketing activities, veterinary medicines, cosmetics, and other industries. The company's business segments are Pharmaceuticals which generates maximum revenue; Consumer products, and Others.
89GF Score
Get the complete analysis for ISX:EPMT
ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:EPMT has been successfully added to your 
